Cargando…

Therapeutic benefits of nanoparticles in stroke

Stroke represents one of the major causes of death and disability worldwide, for which no effective treatments are available. The thrombolytic drug alteplase (tissue plasminogen activator or tPA) is the only treatment for acute ischemic stroke but its use is limited by several factors including shor...

Descripción completa

Detalles Bibliográficos
Autores principales: Panagiotou, Stavros, Saha, Sikha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436818/
https://www.ncbi.nlm.nih.gov/pubmed/26041986
http://dx.doi.org/10.3389/fnins.2015.00182